IHS Chemical Week

Regions :: Western Europe :: Sweden

Roche Sells Four Products to Swedish Firm

10:30 AM MDT | August 25, 2008 | Deepti Ramesh

Roche says it has signed an agreement to sell worldwide rights of four of its pharmaceutical products to specialty pharma company Meda (Solna, Sweden) for a total of €120 million ($176 million). The transaction is expected to close by year-end. The acquired products are an anticoagulant, a loop diuretic, a drug for the treatment of inflammatory and degenerative disorders, and an antidepressant. The products have strong brand names and generate total sales of about SEK500 million ($80 million), Meda says. The most important markets for these products are...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa